在老年患者中治疗风湿性脑膜炎的托西利祖马布:两例病例报告
Kazuhiro Horiuchi1, Shuntaro Nakamura1, Kazuki Yamada1
1Department of Neurology, Hakodate Municipal Hospital, Japan.
Internal medicine (Tokyo, Japan)
|August 6, 2025
概括
类风湿性脑膜炎 (RM) 是类风湿性关节炎 (RA) 的罕见并发症,在老年患者中,托西利祖马布的治疗改善. 这种治疗可以减少皮质类固醇的使用,最大限度地降低相关风险.
科学领域:
- 神经学 神经学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性脑膜炎 (RM) 是类风湿性关节炎 (RA) 的一种罕见的神经并发症.
- 它可以表现为多变性脑膜炎和脑膜炎.
- 患有RA的老年患者在管理神经系统并发症方面面临着独特的挑战.
研究的目的:
- 评估托西利祖马布在治疗类风湿性脑膜炎中的疗效.
- 评估托西利祖马布在老年RM患者中的安全性和类固醇节约潜力.
- 报告RM治疗tocilizumab的患者的临床和放射性结果.
主要方法:
- 两名患有类风湿性脑膜炎的老年患者的回顾性病例审查.
- 初始治疗是使用高剂量的皮质类固醇.
- 随后给托西利祖马布用于类固醇节约效果.
- 对临床和放射学改善的评估.
主要成果:
- 两名患者在托西利祖马布治疗后经历了显著的临床和放射性改善.
- 托西利祖马布促进了皮质类固醇治疗的逐渐成功.
- 在tocilizumab治疗期间没有报告重大不良事件.
结论:
- 托西利祖马布是风湿性脑膜炎的有效治疗选择,特别是在老年患者中.
- 托西利祖马布提供了一种有价值的类固醇节约策略,减轻与长期使用皮质类固醇相关的风险.
- 需要进一步的研究,以在更大的队列中证实这些发现.
相关概念视频
Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
233
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
233
Rheumatic Heart Disease IV: Nursing Management
38
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
38
Pneumonia IV: Management
447
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
447
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203


